Patient Experiences
Mr. Art Cain
Atlanta, GA
Pictured above: Mr. Art Cain, PHEN Survivor Network Member shares his experience with clinical trials.
“I was first diagnosed with prostate cancer in January 2015. My biopsy showed a Gleason score of 8, but a bone and CT scan show no metastasis. Even though scans showed now spread, PSA Levels continued to rise”
Another bone and CT scan showed metastasis. Mr. Cain went on standard-of-care hormone therapy and his PSA levels did decline. However, when his PSA numbers increased again, he learned about another oncologist. He went to a medical appointment where the oncologist discussed a clinical trial at Duke Cancer Center for Mr. Cain. He entered the trial and found the drug combination therapy trial reduced his PSA levels to undetectable levels, which have remained undetectable for the last three years.
Read Blog Post
Mr. Sherman Womack
Boston, MA
Pictured above: Mr. Sherman Womack, prostate cancer survivor.
“Clinical trials were not introduced when I was first diagnosed with prostate cancer in 2004. As a PHEN survivor network member I began learning more about clinical research over the last five years.”
Mr. Womack underwent surgery in February of 2005 followed by radiation treatment. For more than 15 years he has been treated at Massachusetts General Hospital receiving additional treatments of chemotherapy and Androgen Deprivation Therapy (ADT). His oncologist wanted him to start a clinical trial when the chemotherapy stopped working.
He was able to begin the clinical trial in 2022. The trial involved six treatments and Mr. Womack explained that the investigators and staff were very helpful, as he received numerous phone calls checking in on him. This trial proved to be highly successful and involved very minimal side effects. Mr. Womack’s experience highlights how clinical trials can be effective treatments
Mr. DeWayne Charleston
Houston, TX
Pictured above: Dewayne Charleston travels to Ghana while receiving clinical trial treatment and enjoys his time there, surrounded by the smiles of children.
“If it was not for the advocacy of PHEN and their clinical trial navigator, I would have never considered a clinical trial as part of my advance prostate cancer treatment.
I am presently participating in a Phase III clinical trial and still refer to PHEN for support, advocacy, and educational programs like their “clinical trial rally” as I travel along my journey.”
Mr. Euvon Jones
Accokeek, MD
Pictured above: Mr. Euvon Jones, a prostate cancer survivor shares his experience being in a clinical trial.
“I was stage 4, with metastatized prostate cancer, and it had gone to my lymph nodes, through my blood, in my bones, my back and my hip, my chest, it was all over the place!
At that point, I didn’t even know what a prostate was. My doctor suggested an immunotherapy clinical trial. Now, ten years out, my PSA is normal and showing no signs of prostate cancer.”
This information is for educational purposes only and not intended as medical advice.
Patients should consult their medical doctor for advice and recommendations about specific clinical trials.